MoonLake Immunotherapeutics MLTX Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's income tax?
- MoonLake Immunotherapeutics (MLTX) reported income tax of $622K in Q1 2026.
- How has MoonLake Immunotherapeutics's income tax changed year-over-year?
- MoonLake Immunotherapeutics's income tax increased by 306.5% year-over-year, from $153K to $622K.
- What is the long-term trend for MoonLake Immunotherapeutics's income tax?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's income tax has grown at a 156.1% compound annual growth rate (CAGR), from $36.37K to $611K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.